Aiga Therapeutics Overview
- Year Founded
-
2023
- Status
-
Private
- Latest Deal Type
-
Seed
- Investors
-
1
Aiga Therapeutics General Information
Description
Developer of a radioligand therapy intended to target cancer cells, sparing healthy tissue, transforming outcomes. The company's proprietary alpha-particle theranostic platform combines precision targeting with unparalleled cytotoxic power, enabling patients whose cancers have progressed beyond available therapies, a hope through science.
Contact Information
Website
www.aigatherapeutics.comCorporate Office
- 57 Addison Crescent
- North York, Ontario M3B 1K7
- Canada
Corporate Office
- 57 Addison Crescent
- North York, Ontario M3B 1K7
- Canada
Aiga Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Seed Round | 01-May-2026 | Completed | Clinical Trials - General |
Aiga Therapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| FACIT | Venture Capital | Minority |
Aiga Therapeutics FAQs
-
When was Aiga Therapeutics founded?
Aiga Therapeutics was founded in 2023.
-
Where is Aiga Therapeutics headquartered?
Aiga Therapeutics is headquartered in North York, Canada.
-
What industry is Aiga Therapeutics in?
Aiga Therapeutics’s primary industry is Therapeutic Devices.
-
Is Aiga Therapeutics a private or public company?
Aiga Therapeutics is a Private company.
-
What is Aiga Therapeutics’s current revenue?
The current revenue for Aiga Therapeutics is .
-
Who are Aiga Therapeutics’s investors?
FACIT has invested in Aiga Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process